Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linear IgA disease and pregnancy

P M Collier1, S E Kelly, F Wojnarowska

  • 1Department of Dermatology, Bristol Royal Infirmary, United Kingdom.

Journal of the American Academy of Dermatology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of DistillerSR's machine learning-based prioritization tool for title/abstract screening - impact on reviewer-relevant outcomes.

BMC medical research methodology·2020
Same author

The need for longer time horizons for cost-utility evaluation in bullous pemphigoid: reply from the authors.

The British journal of dermatology·2017
Same author

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.

The British journal of dermatology·2017
Same author

Reproductive interference and fecundity affect competitive interactions of sibling species with low mating barriers: experimental and theoretical evidence.

Heredity·2017
Same author

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Host nuclear genotype influences phenotype of a conditional mutualist symbiont.

Journal of evolutionary biology·2016
Same journal

Localized radiation therapy provides more durable disease control than topical steroids in stage IA mycosis fungoides.

Journal of the American Academy of Dermatology·2026
Same journal

Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Li et al., "Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'".

Journal of the American Academy of Dermatology·2026
Same journal

Treatment Utilization Patterns in Cutaneous Lupus Erythematosus: A Single-Center Retrospective Analysis.

Journal of the American Academy of Dermatology·2026
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
See all related articles

Pregnancy generally improves linear IgA dermatosis (LAD), allowing for reduced treatment. However, most patients experience a postpartum relapse, necessitating careful management and counseling for women with LAD considering pregnancy.

Area of Science:

  • Dermatology
  • Obstetrics
  • Immunodermatology

Background:

  • Linear IgA dermatosis (LAD) is a rare autoimmune blistering disease.
  • Little is known about the impact of pregnancy on LAD or vice versa.

Purpose of the Study:

  • To investigate the effects of linear IgA dermatosis on pregnancy.
  • To examine the impact of pregnancy on linear IgA dermatosis.

Main Methods:

  • A cohort of 12 patients with LAD experiencing 19 pregnancies was studied.
  • Disease course, treatment modifications, and maternal/fetal outcomes were assessed.

Main Results:

  • LAD significantly improved during pregnancy, with therapy reduction or cessation possible.
  • Dapsone use during pregnancy showed no adverse effects; labor was uncomplicated.

Related Experiment Videos

  • Postpartum relapse occurred in most patients around 3 months, with some new-onset disease near delivery.

    • Conclusions:

    • Pregnancy is not contraindicated in patients with LAD.
    • Therapy reduction during pregnancy is feasible, and postpartum relapse counseling is recommended.